HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Difficulties in the treatment of rheumatoid arthritis in the presence of cardiovascular events

DOI: https://doi.org/10.29296/25877305-2022-08-14
Issue: 
8
Year: 
2022

E. Sagitova, Candidate of Medical Sciences; O. Kravtsova, Candidate of Medical Sciences
Orenburg State Medical University, Ministry of Health of Russia

Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular events (CVEs). The main factors of cardiovascular mortality in RA are considered to be the rapid progression of atherosclerosis and the development of chronic heart failure. Traditional risk factors, such as hypertension, hyperlipidemia, and obesity, play an important role in the development of CVEs. The paper considers a clinical case of diagnosing RA and difficulties in selecting adequate therapy in the presence of cardiovascular disease.

Keywords: 
therapy
rheumatoid arthritis
brachiocephalic arteries
atherosclerosis
silent myocardial ischemia
blood lipid profile
biological agents.



References: 
  1. Udachkina E.V., Novikova D.S., Popkova T.V. et al. Progression of carotid artery atherosclerosis in patients with early rheumatoid arthritis during treatment to target in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018; 56 (4): 449–55 (in Russ.). DOI: 10.14412/1995-4484-2018-449-455
  2. Fomicheva O.A., Popkova T.V., Krougly L.B. et al. Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis. Kardiologiia. 2021; 61 (1): 12–21 (in Russ.). DOI: 10.18087/cardio.2021.1.n1331
  3. Trukhan D.I., Ivanova D.S., Belus K.D. Rheumatoid arthritis and traditional cardiovascular risk factors: actual aspects of real clinical practice. Consilium Medicum. 2020; 22 (1): 19–25 (in Russ.). DOI: 10.26442/20751753.2020.1.200052
  4. Osipova I.V., Starodubova Yu.N. , Antropova О.N. Prediction of multifocal atherosclerosis in women with rheumatoid arthritis. Russ J Cardiol. 2018; 23 (5): 61–7 (in Russ.). DOI: 10.15829/1560-4071-2018-5-61-67
  5. Serdyuk I.L., Abdrakhmanova A.I., Amirov N.B. et al. Rheumatoid arthritis and cardiovascular diseases. The Bulletin of Contemporary Clinical Medicine. 2020; 13 (4): 86–91 (in Russ.). DOI: 10.20969/VSKM.2020.13(4).86-91
  6. Abdrakhmanova A.I., Amirov N.B., Tsibulkin N.A. Painless myocardial ischemia as a manifestation of coronary heart disease in patients with rheumatoid arthritis. The Bulletin of Contemporary Clinical Medicine. 2020; 13 (2): 50–5 (in Russ.). DOI: 10.20969/VSKM.2020.13(2).50-55
  7. Rebrov A.P. Heart damage in patients with rheumatoid arthritis. South Russian Journal of Therapeutic Practice. 2022; 3 (1): 15–9 (in Russ.). DOI: 10.21886/2712-8156-2022-3-1-15-19
  8. Udachkina E.V., Novikova D.S., Popkova T.V. et al. Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis. Modern Rheumatology Journal. 2013; 7 (3): 25–32 (in Russ.). DOI: 10.14412/1996-7012-2013-7
  9. Amirdzhanova V.N., Pogozheva E.Yu., Karateev A.E. et al. Rheumatoid arthritis in real clinical practice: initiation of therapy with biological agents. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-II») project. Modern Rheumatology Journal. 2019; 13 (3): 30–8 (in Russ.). DOI: 10.14412/1996-7012-2019-3-30-38
  10. Kusevich D.A., Avdeeva A.S. The efficacy and safety of rituximab in rheumatoid arthritis: new evidence. Rheumatology Science and Practice. 2017; 55 (4): 420–8 (in Russ.). DOI: 10.14412/1995-4484-2017-420-428